Phase 2 data shows retatrutide producing roughly 24% body weight loss versus about 21% for tirzepatide in Phase 3 trials
The protective effects of GLP-1 RAs against cardiovascular events have been demonstrated in several studies, thus supporting their application in patients with heart failure with preserved ejection fraction and DM2 ( Taken together, GLP-1 is a major metabolic and regulatory hormone, with many potential therapeutic implications beyond glycemic control, encompassing cardiovascular protection, enhanced renal function, and the potential benefits in hepatic disease
GLP-1s work best when theyre part of a broader health plan, not a quick-click prescription. Check Credentials and Oversight Dr
In particular, vitamin E, after acting as an antioxidant by reducing lipid radicals, is restored to its reduced form by vitamin C
Individuals on Lexapro should avoid taking Adderall, even occasionally, from someone else